Genprex Receives Notice Of Patent Grant For Korean Patent Claiming Reqorsa Immunogene Therapy With PD-1 And PD-L1 Antibodies To Treat Cancers
Genprex Receives Notice Of Patent Grant For Korean Patent Claiming Reqorsa Immunogene Therapy With PD-1 And PD-L1 Antibodies To Treat Cancers
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.